Armando Javier Colón Aponte MSCJ, CBMA, COC, CASCC, CPPM,CFWAP, CWHBP, PCAP™’s Post

View profile for Armando Javier Colón Aponte MSCJ, CBMA, COC, CASCC, CPPM,CFWAP, CWHBP, PCAP™, graphic

DNA MEDSOLUTIONS, LLC℠| Healthcare Optimization & Workforce|Political Science|Healthcare Law-FWA|ASCs Development|CMS Proficiencies Compliance|Real Estate Notary Signing Agent|Value Based|"The Synergy of El and AI"™

The impact of implant pricing on Ambulatory Surgery Centers (ASCs) is a critical challenge affecting profitability. Surgeon alignment at ASCs has led to a substantial reduction in screw prices, emphasizing the need for effective implant cost management without compromising patient care quality. Device Management Companies (DMCs) like Evolent (formerly IPG) play a crucial role in addressing this issue. They leverage contract negotiation, data analytics, and industry relationships to optimize implant costs and revenue cycle management for ASCs. DMCs negotiate favorable pricing, optimize payer contracts, facilitate value-based care models, and provide data-driven insights. Internal strategies are also essential for ASCs, such as strengthening surgeon collaboration, enhancing cost management, and diversifying payer mix. A collaborative approach involving ASCs, surgeons, device manufacturers, payers, and DMCs is key to managing implant costs effectively and ensuring financial sustainability while delivering high-quality patient care. Exploring specific aspects like the role of value-based contracting or challenges in negotiating with device manufacturers can provide deeper insights into optimizing implant costs in ASCs. #theDNAofCostOptimization #ASCsCostEffective #DeviceManagement

Spine surgeon alignment dropped screw price 67% at ASC

Spine surgeon alignment dropped screw price 67% at ASC

beckersspine.com

To view or add a comment, sign in

Explore topics